Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Diener, H-C; Bussone, G; C Van Oene, J; Lahaye, M; Schwalen, S; J Goadsby, P; Study Group, TOPMAT-MIG-201(TOP-CHROME)

doi:10.1111/j.1468-2982.2007.01326.x

Public

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Shared by NobleBlocks on Jul 1, 2007 • 12:00 AM UTC

Authors:

H-C Diener

G Bussone

J C Van Oene

Abstract

The aim of this study was to evaluate the efficacy and tolerability of topiramate for the prevention of chronic migraine in a randomized, double-blind, placebo-controlled trial. Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice. Preventive treatment...

Discussions